Back
Aurinia Pharmaceuticals Vs. Xenon Pharmaceuticals Industry Stock Comparison
Sell
46
AUPH
Aurinia Pharmaceuticals
Last Price:
5.79
Seasonality Move:
0.65%
Sell
49
XENE
Xenon Pharmaceuticals
Last Price:
40.40
Seasonality Move:
7.63%
Sell
46
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $5.76. The Score for AUPH is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- AUPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Xenon Pharmaceuticals (XENE)
is a Sell
Is Xenon Pharmaceuticals a Buy, Sell or Hold?
- The current Xenon Pharmaceuticals [XENE] share price is $39.80. The Score for XENE is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- XENE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $5.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing slight buying pressure.
XENE Stock Price Chart
What is Xenon Pharmaceuticals's stock price today?
-
The Xenon Pharmaceuticals share price today is $39.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XENE is experiencing slight selling pressure.
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 69.62 | Buy |
| Chaikin Money Flow: | 518324 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.9 - 5.34) | Buy |
| Bollinger Bands (100): | (4.84 - 7.76) | Sell |
XENE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 39.22 | Sell |
| Chaikin Money Flow: | -106521 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.03 - 42.59) | Sell |
| Bollinger Bands (100): | (41.73 - 47.17) | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.3 | Buy |
| 20-day SMA: | 5.16 | Buy |
| 50-day SMA: | 5.12 | Buy |
| 200-day SMA: | 7.44 | Sell |
| 8-day EMA: | 5.4 | Buy |
| 20-day EMA: | 5.23 | Buy |
| 50-day EMA: | 5.41 | Buy |
| 200-day EMA: | 7.07 | Sell |
XENE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.95 | Sell |
| 20-day SMA: | 41.4 | Sell |
| 50-day SMA: | 42.24 | Sell |
| 200-day SMA: | 40.04 | Sell |
| 8-day EMA: | 40.79 | Sell |
| 20-day EMA: | 41.38 | Sell |
| 50-day EMA: | 42.28 | Sell |
| 200-day EMA: | 41.09 | Sell |
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
Xenon Pharmaceuticals Earnings Growth & XENE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.30 per share.
Aurinia Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xenon Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||